Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Alspaugh Jonathan
Chief Financial Officer at Spyre Therapeutics. Filing since 16 Aug 2021.
CIK 0001868112
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE
Spyre Therapeutics, Inc.
11 Mar 2022
Chief Financial Officer
Bought
75,000
$156.00K
83.0%
SYRE
Spyre Therapeutics, Inc.
9 Dec 2021
Chief Financial Officer
Bought
50,000
$186.00K
124%
SYRE
Spyre Therapeutics, Inc.
18 Aug 2021
Chief Financial Officer
Bought
7,200
$48.40K
21.7%
SYRE
Spyre Therapeutics, Inc.
17 Aug 2021
Chief Financial Officer
Bought
23,392
$151.98K
239%
SYRE
Spyre Therapeutics, Inc.
16 Aug 2021
Chief Financial Officer
Bought
9,780
$62.28K
opened
5 decisions on file.
